Company intelligence / Profile preview

Kodak

Rochester, New York, United Stateskodak.com ↗

Ownership: Public · KODK
Employees: ~1250
Development stage: Commercial

Overview

Kodak’s Advanced Materials & Chemicals unit will soon manufacture FDA-regulated diagnostic test reagents at a new cGMP facility in Rochester, NY. No clinical results reported as the company does not develop drugs but manufactures components and reagents for the healthcare sector.

Modalities: Diagnostic reagent
Industry: Chemicals & Materials

Financials

Market cap: $724.5M
Total revenue: $1.1B
Enterprise value: $511.5M

Beyond the preview

Go deeper on Kodak.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kodak.